NCT03488238

Brief Summary

The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above. This is a prospective, non-blinded, non-randomized study of the Oxygen Reserve Index (ORi) in a clinical setting. It is designed to evaluate the correlations with ORi and changes in PaO2 and the potential use of ORi as an early warning of impending arterial oxygen desaturation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 4, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 19, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 19, 2018

Completed
3 years until next milestone

Results Posted

Study results publicly available

September 20, 2021

Completed
Last Updated

September 20, 2021

Status Verified

August 1, 2021

Enrollment Period

2 months

First QC Date

March 29, 2018

Results QC Date

August 23, 2021

Last Update Submit

August 23, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Sensitivity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.

    ORi is an index value without a unit and ORi does not directly measure PaO2. Therefore, sensitivity is calculated to evaluate changes in ORi relative to the changes in PaO2.

    Less than 30 mins

  • Specificity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.

    ORi is an index value without a unit and ORi does not directly measure PaO2. Therefore specificity is calculated to evaluate changes in ORi relative to the changes in PaO2.

    Less than 30 mins

  • Concordance for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.

    ORi is an index value without a unit and ORi does not directly measure PaO2. Therefore concordance is calculated to evaluate changes in ORi relative to the changes in PaO2.

    Less than 30 minutes

Study Arms (1)

ORi sensor

EXPERIMENTAL

All subjects are enrolled in the test group and receive an ORi sensor during their scheduled, general surgery procedure

Device: ORi sensor

Interventions

Noninvasive pulse oximeter sensor that is placed on the finger for measurement of ORi

ORi sensor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than 18 years
  • ASA physical status III or IV
  • Scheduled for an elective surgical procedure requiring endotracheal intubation and the use of an arterial pressure monitoring catheter placed prior to induction of general anesthesia

You may not qualify if:

  • Age less than 18 years
  • Adults unable to give primary consent
  • Pregnancy
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis

Sacramento, California, 95817, United States

Location

MeSH Terms

Conditions

Hyperoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Cristina Johnson
Organization
Masimo Corporation

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2018

First Posted

April 4, 2018

Study Start

August 1, 2018

Primary Completion

September 19, 2018

Study Completion

September 19, 2018

Last Updated

September 20, 2021

Results First Posted

September 20, 2021

Record last verified: 2021-08

Locations